Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric bone marrow transplantation: current progress and future prospects.

P M Sondel, M E Trigg, R Hong

    Pediatrics
    |December 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy.

    bioRxiv : the preprint server for biology·2023
    Same author

    Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial.

    Cancer immunology, immunotherapy : CII·2023
    Same author

    Marrow-ablative chemotherapy followed by tandem autologous hematopoietic cell transplantation in pediatric patients with malignant brain tumors.

    Bone marrow transplantation·2017
    Same author

    Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the 'Head Start' trials, 1991-2009.

    Bone marrow transplantation·2016
    Same author

    Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease.

    Bone marrow transplantation·2016
    Same author

    Allele-specific alien-driven diversity, immune responsiveness and MHC-restriction.

    Immunology today·2014
    Same journal

    Measles-Associated Stridor.

    Pediatrics·2026
    Same journal

    MTHFR, Pneumonia, and Thrombosis in Children: A Gene-Infection Interaction.

    Pediatrics·2026
    Same journal

    Early Adulthood Outcomes Among Individuals With Neurologic Impairment and Technology Assistance.

    Pediatrics·2026
    Same journal

    Video vs Telephone Consultations for Pediatric Quality of Care in Emergency Departments.

    Pediatrics·2026
    Same journal

    A Resource to Understand and Prevent Sudden Unexpected Infant Deaths.

    Pediatrics·2026
    Same journal

    Influenza Vaccine Effectiveness Against Pediatric Death in the United States: 2016-2025.

    Pediatrics·2026
    See all related articles

    Researchers are improving bone marrow transplantation (BMT) to increase patient survival and reduce complications. This aims to make BMT a viable treatment for more patients with serious blood, immune, or metabolic disorders.

    Area of Science:

    • Hematology
    • Immunology
    • Transplantation Medicine

    Background:

    • Bone marrow transplantation (BMT) is a critical therapeutic option for various diseases.
    • Significant challenges remain, including patient survival, treatment-related morbidity, and donor availability.

    Purpose of the Study:

    • To advance clinical and laboratory research addressing complications in bone marrow transplantation.
    • To enhance long-term patient survival and reduce the adverse effects of BMT.
    • To expand BMT eligibility to patients lacking HLA-identical siblings and for currently untreated fatal disorders.

    Main Methods:

    • Ongoing clinical trials and laboratory investigations.
    • Focus on mitigating toxicity and improving patient outcomes post-transplant.

    Related Experiment Videos

    Main Results:

    • Research efforts are focused on resolving key complications associated with BMT.
    • Improvements in BMT are expected to increase its applicability and success rates.

    Conclusions:

    • Addressing BMT complications is crucial for expanding its therapeutic reach.
    • Reduced toxicity and improved outcomes will position BMT as a primary treatment for a wider range of fatal hematologic, immunologic, and metabolic diseases.